The global High-end Cellomics Market, according to Future Market Insights (FMI), is entering a strong growth phase, driven by increasing pharmaceutical investment in high-content screening, rising adoption of single-cell genomics technologies, and expanding demand for advanced cellular analysis in precision medicine research. The market is projected to grow from USD 397.1 million in 2026 to USD...